These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34415792)
1. Liu L; Jia S; Jin X; Zhu S; Zhang S DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792 [TBL] [Abstract][Full Text] [Related]
2. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. Cui Y; Zhang C; Wang Y; Ma S; Cao W; Guan F Life Sci; 2020 Feb; 243():117230. PubMed ID: 31923422 [TBL] [Abstract][Full Text] [Related]
3. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Zhou R; Sun Z; Zhou R; Wang M; Zhuo Q; Deng X; Wang Z; Xu Y Med Oncol; 2024 Oct; 41(11):285. PubMed ID: 39402288 [TBL] [Abstract][Full Text] [Related]
4. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma. Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538 [TBL] [Abstract][Full Text] [Related]
5. Identification prognosis-associated immune genes in colon adenocarcinoma. Miao Y; Wang J; Ma X; Yang Y; Mi D Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Sine Oculis Homeobox Homolog 2 Predicts Poor Survival and Clinical Parameters of Patients with Colon Adenocarcinoma. Jiang Y; Zhou B; Liang B; Zeng F; Zou Z Ann Clin Lab Sci; 2020 Nov; 50(6):717-725. PubMed ID: 33334785 [TBL] [Abstract][Full Text] [Related]
7. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
8. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
9. Investigation and verification of the clinical significance and perspective of natural killer group 2 member D ligands in colon adenocarcinoma. Ruan GT; Wang S; Zhu LC; Liao XW; Wang XK; Liao C; Yan L; Xie HL; Gong YZ; Gan JL; Gao F Aging (Albany NY); 2021 Apr; 13(9):12565-12586. PubMed ID: 33909599 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related]
11. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma. Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma. Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809 [TBL] [Abstract][Full Text] [Related]
14. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis. Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma. Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253 [TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma. Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481 [TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis. Dong S; Ding Z; Zhang H; Chen Q Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719 [No Abstract] [Full Text] [Related]
18. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients. Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303 [TBL] [Abstract][Full Text] [Related]
19. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma. Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978 [TBL] [Abstract][Full Text] [Related]
20. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma. Lin Y; Li Y; Chen Y; Zhang Z Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]